Annual Drug Patent Expirations for ROCKLATAN
Rocklatan is a drug marketed by Alcon Labs Inc and is included in one NDA. It is available from one supplier. There are sixteen patents protecting this drug.
Drug patent litigation for ROCKLATAN.
This drug has sixty-four patent family members in fourteen countries.
The generic ingredient in ROCKLATAN is latanoprost; netarsudil dimesylate. One supplier is listed for this compound. Additional details are available on the latanoprost; netarsudil dimesylate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
